Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC α-Glucosidase-IN-22 | 2870693-28-8 | C14H11N3O2S | 5 MG
SDP

Catalog No. 5000372885
Encompass_Preferred

α-Glucosidase-IN-22 (compound 7i), a benzimidazole, is a potent α-glucosidase inhibitor with an IC₅₀ of 0.64 μM. It is also a potent anti-diabetic agent with potential for type 2 diabetes mellitus (T2DM) research.

  • Potent α-glucosidase inhibitor with an IC₅₀ of 0.64 μM.
  • Potent anti-diabetic agent.
  • Potential for type 2 diabetes mellitus (T2DM) research.
  • Store powder at -20°C for 3 years, 4°C for 2 years.
  • Store in solvent at -80°C for 6 months, -20°C for 1 month.

Catalog No. 50-003-72885 Supplier Medchemexpress LLC Supplier No. HY1521585MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

α-Glucosidase-IN-22 (compound 7i), a benzimidazole, is a potent α-glucosidase inhibitor with an IC₅₀ of 0.64 μM. It is also a potent anti-diabetic agent with potential for type 2 diabetes mellitus (T2DM) research.

  • Potent α-glucosidase inhibitor with an IC₅₀ of 0.64 μM.
  • Potent anti-diabetic agent.
  • Potential for type 2 diabetes mellitus (T2DM) research.
  • Store powder at -20°C for 3 years, 4°C for 2 years.
  • Store in solvent at -80°C for 6 months, -20°C for 1 month.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.